MyPureSkin is redefining skin health through clinically validated nutricosmetics, combining nutritional science, longevity research, and Swiss innovation to support skin structure, regeneration, and healthy ageing from within.

For Edgar Brandt and Tatiana Brandt, co-founders of MyPureSkin S.A, being recognised among the 20 Most Innovative Healthcare Companies to Watch in 2026 represents far more than an accolade. It serves as confirmation that the question they began asking more than fifteen years ago — why skin was not being treated in the same way as every other organ in the body — was the right one.

When MyPureSkin was founded in Switzerland’s Health Valley, the nutricosmetics category was still in its infancy. The beauty industry remained heavily focused on topical skincare, while the wider health and wellness sector had yet to fully embrace skin as a biological system deserving of nutritional science. MyPureSkin was operating in a space that few had properly defined, a position that initially felt isolated but later became one of the company’s strongest strategic advantages.

The Founding Conviction: Skin as a Living Organ

Tatiana Brandt’s background in aesthetic medicine shaped the foundation of the company. Through working closely with patients in clinical settings, she observed a recurring issue that topical treatments alone could not resolve: the structural deterioration of the skin from within.

Collagen networks weakened, cellular renewal slowed, and oxidative damage accumulated in ways that external products could temporarily disguise but not fundamentally correct. The skin was ageing biologically, while the solutions available to practitioners remained largely cosmetic.

From this observation emerged a concept that was considered highly unconventional at the time: if skin is the body’s largest organ, it should receive the same science-led nutritional support as the cardiovascular, digestive, or musculoskeletal systems. “Beauty from within” was not viewed as a marketing slogan, but as a biological proposition requiring scientific validation.

That philosophy led to years of research and development focused on ingredient selection, synergistic formulation, and bioavailability before the launch of the company’s first product.

When MyCollagenLift launched in 2019, it was positioned not simply as another collagen supplement, but as a comprehensive nutricosmetic designed to support the skin’s own structural mechanisms. The distinction was intentional. MyPureSkin was never intended to become solely a collagen brand; it was conceived as a skin longevity company.

Nutrigevity™: A Proprietary Scientific Framework

As the science underpinning the brand evolved, MyPureSkin formalised its methodology through a proprietary framework known as Nutrigevity™.

The framework was developed as a synergistic formulation architecture designed to support the biological foundations of living tissue by combining clinical expertise with nutritional biology.

Nutrigevity™ is structured around three key biological pillars.

The first, Structure, focuses on supporting the extracellular matrix, including collagen, elastin networks, and hyaluronic acid responsible for skin density and firmness.

The second, Signalling, is designed to activate the body’s natural repair mechanisms and stimulate cellular processes that decline with age.

The third pillar, Regeneration, centres on protecting and nourishing cells over time through antioxidants, enzymes, and targeted nutrients intended to preserve long-term biological vitality.

The framework continues to be refined by a scientific committee comprising specialists across clinical medicine, plastic surgery, gynaecology, micronutrition, and skin biology. According to the company, Nutrigevity™ functions not as a marketing concept, but as the scientific logic underpinning every formulation decision.

Bringing Clinical Validation to Nutricosmetics

One of the most defining strategic decisions in MyPureSkin’s development was the choice to subject its flagship formula to independent clinical scrutiny in a category where rigorous testing is often limited.

MyCollagenLift underwent a randomised, double-blind, placebo-controlled study conducted by the Skin Test Institute involving 43 women aged between 40 and 65 over a twelve-week period.

Results were measured using validated dermatological instruments across hydration, elasticity, firmness, dermal density, and radiance.

According to the company, the findings demonstrated up to 84% improvement in dermal hydration, a reduction in wrinkle depth of up to 43%, a 264% improvement in skin elasticity, and a 294% increase in skin firmness compared with placebo measurements.

For MyPureSkin, the decision to pursue clinical validation was both scientific and strategic, helping position the brand with consumers and healthcare professionals seeking evidence-based wellness solutions.

The antioxidant performance of the company’s formulas was also independently assessed using the PAOT scale developed by the Institut Européen des Antioxydants. While a score of 70 represents the average benchmark for nutricosmetics, MyPureSkin’s formulas reportedly achieved scores ranging from 169 to 674, results the institute described as reflecting exceptional quality.

A Market Driven by Prevention and Longevity

The broader market conditions surrounding MyPureSkin’s growth reflect significant shifts in consumer behaviour and healthcare priorities.

The global nutricosmetics market, valued at approximately $10.7 billion in 2025, is projected to reach $15 billion by 2030, driven by growing consumer demand for preventative wellness solutions.

At the same time, the wider longevity sector is forecast to expand from $27.6 billion in 2025 to approximately $67 billion by 2035 as consumers increasingly focus on extending healthspan rather than simply managing illness.

Nutraceuticals and dietary supplements currently represent one of the largest segments within the longevity economy, while wellness clinics and longevity-focused spas are expected to become some of the fastest-growing distribution channels globally.

MyPureSkin is positioning itself at the intersection of these trends as a clinically validated, Swiss-manufactured nutricosmetics company operating across Switzerland, France, and the United States, with active markets spanning Europe, North America, the Middle East, and Australia.

Expanding from Switzerland to Global Markets

The company’s international expansion has followed a deliberate trajectory.

From its headquarters in Nyon, Switzerland, MyPureSkin first expanded across European markets before establishing a US entity in New York.

By 2024, the company had established a presence across four continents, reflecting growing international demand for science-backed longevity and skin health solutions.

The United States represents a particularly significant strategic market for the business. The US longevity and wellness sector is not only the world’s largest, but also increasingly informed by scientific discussions surrounding cellular ageing, oxidative stress, and the gut-skin axis.

Concepts that were once confined to specialist medical discussions have increasingly entered mainstream wellness culture, positioning MyPureSkin’s long-standing philosophy in direct alignment with evolving consumer awareness.

The Future of Longevity and Skin Health

As interest in longevity accelerates globally, the sector is attracting growing attention from investors, pharmaceutical researchers, healthcare providers, and consumer wellness brands alike.

Skin occupies a unique position within this movement as one of the most visible indicators of biological ageing.

However, with rapid market growth comes increasing scrutiny. For MyPureSkin, maintaining scientific credibility remains central to the company’s long-term vision.

The founders believe that sustainable innovation within longevity and nutricosmetics depends on rigorous clinical validation, transparent formulation practices, supply chain integrity, and regulatory compliance across international markets.

Rather than viewing these standards as obstacles to growth, the company sees them as the foundation of lasting credibility.

MyPureSkin was built around those principles long before the market demanded them. That early commitment to scientific discipline, the founders believe, is what now allows the company to expand internationally with confidence while continuing to strengthen its position within the evolving global longevity economy.

As the founders say: Ageing is inevitable. Ageing well is a choice. 

To find out more about MyPureSkin SA, visit https://mypureskin.eu